Taiwan FDA registration 1f2ee118d93ce125ffbef67778ce3e03
HemosIL UF Heparin Controls
TW: 希摩西爾未分段肝素品管液
Taiwan·Risk Class 2·MD·INSTRUMENTATION LABORATORY CO.·Registered Aug 07, 2013 – Aug 07, 2028ActiveRegistration details
- Analysis ID
- 1f2ee118d93ce125ffbef67778ce3e03
- License Form
- Ministry of Health Medical Device Import No. 025256
- Customs Code
- DHA05602525602
Company information
- Manufacturer
- INSTRUMENTATION LABORATORY CO.
- Manufacturer Country
- United States
- Authorized Representative
- Werfen Taiwan Limited
Product details
- Intended Use
- This product is used with IL blood coagulation instrument system (ACL TOP series, ACL ELITE/ELITE PRO/8/9/10000, and ACL Futura/ACL Advance) as a liquid heparin reagent for unfractionated heparin (UFH) quality control.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B5425 Multifunctional equipment for in vitro agglutination research
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Aug 07, 2013
- Expiry Date
- Aug 07, 2028
About this record
Access comprehensive regulatory information for HemosIL UF Heparin Controls in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1f2ee118d93ce125ffbef67778ce3e03 and manufactured by INSTRUMENTATION LABORATORY CO.. The authorized representative in Taiwan is Werfen Taiwan Limited.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices